{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:54:32Z","timestamp":1774634072877,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T00:00:00Z","timestamp":1371686400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2172-14-26","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T04:14:19Z","timestamp":1371701659000},"source":"Crossref","is-referenced-by-count":15,"title":["Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohort"],"prefix":"10.1186","volume":"14","author":[{"given":"Damalie","family":"Nakanjako","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Ssewanyana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Nabatanzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Kiragga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses R","family":"Kamya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huyen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harriet","family":"Mayanja-Kizza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,20]]},"reference":[{"issue":"5342","key":"532_CR1","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","volume":"278","author":"ES Rosenberg","year":"1997","unstructured":"Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, Walker BD: Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science. 1997, 278 (5342): 1447-1450. 10.1126\/science.278.5342.1447.","journal-title":"Science"},{"issue":"20","key":"532_CR2","doi-asserted-by":"publisher","first-page":"10900","DOI":"10.1128\/JVI.77.20.10900-10909.2003","volume":"77","author":"C Iyasere","year":"2003","unstructured":"Iyasere C, Tilton JC, Johnson AJ, Younes S, Yassine-Diab B, Sekaly RP, Kwok WW, Migueles SA, Laborico AC, Shupert WL: Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J Virol. 2003, 77 (20): 10900-10909. 10.1128\/JVI.77.20.10900-10909.2003.","journal-title":"J Virol"},{"issue":"Suppl 1","key":"532_CR3","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1002\/cyto.b.20391","volume":"74","author":"DK Glencross","year":"2008","unstructured":"Glencross DK, Janossy G, Coetzee LM, Lawrie D, Scott LE, Sanne I, McIntyre JA, Stevens W: CD8\/CD38 activation yields important clinical information of effective antiretroviral therapy: findings from the first year of the CIPRA-SA cohort. Cytometry B Clin Cytom. 2008, 74 (Suppl 1): S131-140.","journal-title":"Cytometry B Clin Cytom"},{"issue":"3","key":"532_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.it.2010.12.002","volume":"32","author":"A Guihot","year":"2011","unstructured":"Guihot A, Bourgarit A, Carcelain G, Autran B: Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus. Trends Immunol. 2011, 32 (3): 131-137. 10.1016\/j.it.2010.12.002.","journal-title":"Trends Immunol"},{"issue":"3","key":"532_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1086\/431484","volume":"41","author":"GR Kaufmann","year":"2005","unstructured":"Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Rickenbach M, Hirschel B: Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells\/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clin Infect Dis. 2005, 41 (3): 361-372. 10.1086\/431484.","journal-title":"Clin Infect Dis"},{"key":"532_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1742-6405-5-23","volume":"5","author":"D Nakanjako","year":"2008","unstructured":"Nakanjako D, Kiragga A, Ibrahim F, Castelnuovo B, Kamya MR, Easterbrook PJ: Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significance. AIDS Res Ther. 2008, 5: 23-10.1186\/1742-6405-5-23.","journal-title":"AIDS Res Ther"},{"issue":"4","key":"532_CR7","first-page":"179","volume":"11","author":"D Nakanjako","year":"2009","unstructured":"Nakanjako D, Colebunders R, Coutinho AG, Kamya MR: Strategies to optimize HIV treatment outcomes in resource-limited settings. AIDS Rev. 2009, 11 (4): 179-189.","journal-title":"AIDS Rev"},{"issue":"2","key":"532_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1006\/clim.2001.5164","volume":"102","author":"CG Lange","year":"2002","unstructured":"Lange CG, Valdez H, Medvik K, Asaad R, Lederman MM: CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection. Clin Immunol. 2002, 102 (2): 154-161. 10.1006\/clim.2001.5164.","journal-title":"Clin Immunol"},{"issue":"4","key":"532_CR9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1086\/318545","volume":"183","author":"JN Blankson","year":"2001","unstructured":"Blankson JN, Gallant JE, Siliciano RF: Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution. J Infect Dis. 2001, 183 (4): 657-661. 10.1086\/318545.","journal-title":"J Infect Dis"},{"issue":"5","key":"532_CR10","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/342559","volume":"186","author":"M Markowitz","year":"2002","unstructured":"Markowitz M, Jin X, Hurley A, Simon V, Ramratnam B, Louie M, Deschenes GR, Ramanathan M, Barsoum S, Vanderhoeven J: Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination. J Infect Dis. 2002, 186 (5): 634-643. 10.1086\/342559.","journal-title":"J Infect Dis"},{"issue":"12","key":"532_CR11","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1128\/JVI.76.12.5925-5936.2002","volume":"76","author":"BE Palmer","year":"2002","unstructured":"Palmer BE, Boritz E, Blyveis N, Wilson CC: Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication. J Virol. 2002, 76 (12): 5925-5936. 10.1128\/JVI.76.12.5925-5936.2002.","journal-title":"J Virol"},{"issue":"3","key":"532_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1086\/595851","volume":"48","author":"L Gazzola","year":"2009","unstructured":"Gazzola L, Tincati C, Bellistri GM, Monforte A, Marchetti G: The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options. Clin Infect Dis. 2009, 48 (3): 328-337.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"532_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/QAI.0b013e31814278c0","volume":"46","author":"MR Kamya","year":"2007","unstructured":"Kamya MR, Mayanja-Kizza H, Kambugu A, Bakeera-Kitaka S, Semitala F, Mwebaze-Songa P, Castelnuovo B, Schaefer P, Spacek LA, Gasasira AF: Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr. 2007, 46 (2): 187-193. 10.1097\/QAI.0b013e31814278c0.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"14","key":"532_CR14","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/00002030-200109280-00002","volume":"15","author":"L Teixeira","year":"2001","unstructured":"Teixeira L, Valdez H, McCune JM, Koup RA, Badley AD, Hellerstein MK, Napolitano LA, Douek DC, Mbisa G, Deeks S: Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS. 2001, 15 (14): 1749-1756. 10.1097\/00002030-200109280-00002.","journal-title":"AIDS"},{"issue":"8","key":"532_CR15","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.vaccine.2010.12.066","volume":"29","author":"C Kityo","year":"2011","unstructured":"Kityo C, Bousheri S, Akao J, Ssali F, Byaruhanga R, Ssewanyana I, Muloma P, Myalo S, Magala R, Lu Y: Therapeutic immunization in HIV infected Ugandans receiving stable antiretroviral treatment: a Phase I safety study. Vaccine. 2011, 29 (8): 1617-1623. 10.1016\/j.vaccine.2010.12.066.","journal-title":"Vaccine"},{"issue":"8","key":"532_CR16","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1182\/blood-2006-07-034785","volume":"109","author":"A Boasso","year":"2007","unstructured":"Boasso A, Herbeuval JP, Hardy AW, Anderson SA, Dolan MJ, Fuchs D, Shearer GM: HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood. 2007, 109 (8): 3351-3359. 10.1182\/blood-2006-07-034785.","journal-title":"Blood"},{"issue":"8","key":"532_CR17","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.4049\/jimmunol.170.8.4260","volume":"170","author":"T Kawamura","year":"2003","unstructured":"Kawamura T, Gatanaga H, Borris DL, Connors M, Mitsuya H, Blauvelt A: Decreased stimulation of CD4+ T cell proliferation and IL-2 production by highly enriched populations of HIV-infected dendritic cells. J Immunol. 2003, 170 (8): 4260-4266.","journal-title":"J Immunol"},{"key":"532_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2334-11-43","volume":"11","author":"D Nakanjako","year":"2011","unstructured":"Nakanjako D, Ssewanyana I, Mayanja-Kizza H, Kiragga A, Colebunders R, Manabe YC, Nabatanzi R, Kamya MR, Cao H: High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort. BMC Infect Dis. 2011, 11: 43-10.1186\/1471-2334-11-43.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"532_CR19","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1172\/JCI45157","volume":"121","author":"M Zeng","year":"2011","unstructured":"Zeng M, Smith AJ, Wietgrefe SW, Southern PJ, Schacker TW, Reilly CS, Estes JD, Burton GF, Silvestri G, Lifson JD: Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections. J Clin Invest. 2011, 121 (3): 998-1008. 10.1172\/JCI45157.","journal-title":"J Clin Invest"},{"issue":"1","key":"532_CR20","doi-asserted-by":"publisher","first-page":"e1002437","DOI":"10.1371\/journal.ppat.1002437","volume":"8","author":"M Zeng","year":"2012","unstructured":"Zeng M, Southern PJ, Reilly CS, Beilman GJ, Chipman JG, Schacker TW, Haase AT: Lymphoid tissue damage in HIV-1 infection depletes naive T cells and limits T cell reconstitution after antiretroviral therapy. PLoS Pathog. 2012, 8 (1): e1002437-10.1371\/journal.ppat.1002437.","journal-title":"PLoS Pathog"},{"key":"532_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2011.06284.x","volume":"1247","author":"PJ Lane","year":"2012","unstructured":"Lane PJ, Gaspal FM, McConnell FM, Kim MY, Anderson G, Withers DR: Lymphoid tissue inducer cells: innate cells critical for CD4+ T cell memory responses?. Ann N Y Acad Sci. 2012, 1247: 1-15. 10.1111\/j.1749-6632.2011.06284.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"1\u20132","key":"532_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jim.2012.02.013","volume":"378","author":"K Moodley","year":"2012","unstructured":"Moodley K, Coetzee LM, Glencross DK: Decentralised CD38 activation monitoring: aspects of practical implementation and standardisation. J Immunol Methods. 2012, 378 (1\u20132): 121-127.","journal-title":"J Immunol Methods"},{"issue":"9","key":"532_CR23","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1086\/651689","volume":"50","author":"E Negredo","year":"2010","unstructured":"Negredo E, Massanella M, Puig J, Perez-Alvarez N, Gallego-Escuredo JM, Villarroya J, Villarroya F, Molto J, Santos JR, Clotet B: Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications. Clin Infect Dis. 2010, 50 (9): 1300-1308. 10.1086\/651689.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"532_CR24","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/01.aids.0000226954.95094.39","volume":"20","author":"A Mocroft","year":"2006","unstructured":"Mocroft A, Phillips AN, Ledergerber B, Katlama C, Chiesi A, Goebel FD, Knysz B, Antunes F, Reiss P, Lundgren JD: Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia. AIDS. 2006, 20 (8): 1141-1150. 10.1097\/01.aids.0000226954.95094.39.","journal-title":"AIDS"},{"issue":"3","key":"532_CR25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1086\/510746","volume":"44","author":"RD Moore","year":"2007","unstructured":"Moore RD, Keruly JC: CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis. 2007, 44 (3): 441-446. 10.1086\/510746.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"532_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1468-1293.2007.00446.x","volume":"8","author":"V Le Moing","year":"2007","unstructured":"Le Moing V, Thiebaut R, Chene G, Sobel A, Massip P, Collin F, Meyohas M, Al Kaied F, Leport C, Raffi F: Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies\/mL during treatment with antiretroviral drugs. HIV Med. 2007, 8 (3): 156-163. 10.1111\/j.1468-1293.2007.00446.x.","journal-title":"HIV Med"},{"issue":"6","key":"532_CR27","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1084\/jem.20040874","volume":"200","author":"JM Brenchley","year":"2004","unstructured":"Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, Nguyen PL, Khoruts A, Larson M, Haase AT: CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004, 200 (6): 749-759. 10.1084\/jem.20040874.","journal-title":"J Exp Med"},{"issue":"3","key":"532_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1056\/NEJMoa1110187","volume":"368","author":"T Le","year":"2013","unstructured":"Le T, Wright EJ, Smith DM, He W, Catano G, Okulicz JF, Young JA, Clark RA, Richman DD, Little SJ: Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med. 2013, 368 (3): 218-230. 10.1056\/NEJMoa1110187.","journal-title":"N Engl J Med"},{"issue":"12","key":"532_CR29","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1084\/jem.20042408","volume":"201","author":"K Sacre","year":"2005","unstructured":"Sacre K, Carcelain G, Cassoux N, Fillet AM, Costagliola D, Vittecoq D, Salmon D, Amoura Z, Katlama C, Autran B: Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease. J Exp Med. 2005, 201 (12): 1999-2010. 10.1084\/jem.20042408.","journal-title":"J Exp Med"},{"key":"532_CR30","volume-title":"Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents: Management of the treatment experienced patient; Virologic and Immunological failure","author":"WHO","year":"2010","unstructured":"WHO: Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents: Management of the treatment experienced patient; Virologic and Immunological failure. 2010,\n                    http:\/\/www.who.int\/hiv\/pub\/arv\/adult2010\/en\/index.htm\n                    \n                  ,"},{"issue":"10","key":"532_CR31","doi-asserted-by":"publisher","first-page":"e47485","DOI":"10.1371\/journal.pone.0047485","volume":"7","author":"F Lori","year":"2012","unstructured":"Lori F, De Forni D, Katabira E, Baev D, Maserati R, Calarota SA, Cahn P, Testori M, Rakhmanova A, Stevens MR: VS411 reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for AntiViral-HyperActivation limiting therapeutics. PLoS One. 2012, 7 (10): e47485-10.1371\/journal.pone.0047485.","journal-title":"PLoS One"},{"issue":"12","key":"532_CR32","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1182\/blood-2011-01-329060","volume":"118","author":"S Piconi","year":"2011","unstructured":"Piconi S, Parisotto S, Rizzardini G, Passerini S, Terzi R, Argenteri B, Meraviglia P, Capetti A, Biasin M, Trabattoni D: Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders. Blood. 2011, 118 (12): 3263-3272. 10.1182\/blood-2011-01-329060.","journal-title":"Blood"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2172-14-26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2172-14-26\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2172-14-26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T21:21:26Z","timestamp":1548105686000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/1471-2172-14-26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,20]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["532"],"URL":"https:\/\/doi.org\/10.1186\/1471-2172-14-26","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,20]]},"article-number":"26"}}